Treatment duration for patients with drug-resistant tuberculosis, United States

Emerg Infect Dis. 2012 Jul;18(7):1201-2. doi: 10.3201/eid1807.120261.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Antitubercular Agents / pharmacology
  • Antitubercular Agents / therapeutic use
  • Drug Administration Schedule
  • Drug Resistance, Bacterial
  • Drug Resistance, Multiple, Bacterial
  • Humans
  • Isoniazid / administration & dosage*
  • Isoniazid / pharmacology
  • Isoniazid / therapeutic use
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects*
  • Rifampin / administration & dosage*
  • Rifampin / pharmacology
  • Rifampin / therapeutic use
  • Time Factors
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Multidrug-Resistant / microbiology
  • United States / epidemiology

Substances

  • Antitubercular Agents
  • Isoniazid
  • Rifampin